ERN1 and cancer: It is considered a double-edged sword with respect to cancers, as long-term exposure to an inflammatory environment can either promote or prevent tumorigenesis.4 ORIN1001, a pharmacological inhibitor of IRE1α, specifically inhibits the RNase activity without affecting its splicing function.